Loading organizations...
Key people at BlueIO.
BlueIO was founded in 2012 by Dave Furneaux (Founder, Chairman and CEO).
BlueIO operates as a startup studio and investment firm, concentrating on building and funding technology-based companies. The firm applies a hybrid approach, combining strategic capital allocation with hands-on company creation, particularly within high-impact sectors. This model aims to cultivate robust enterprises from conception through growth, ensuring alignment with market needs and technological advancements.
Founded in 2012 by Dave Furneaux, BlueIO emerged from the recognition that a more integrated approach to venture creation and funding was needed. Furneaux’s vision was to establish a platform that not only invested in promising ventures but also actively participated in their development, addressing pressing global challenges through purposeful enterprise building.
BlueIO primarily supports founders and nascent companies within sectors such as healthcare, technology, consumer goods, and cybersecurity. The firm’s overarching vision is to foster the growth of companies that are inherently purpose-driven, leveraging innovation to tackle significant societal problems. They aim to empower the next generation of enterprises to deliver lasting positive impact.
BlueIO was founded in 2012 by Dave Furneaux (Founder, Chairman and CEO).
Key people at BlueIO.
BlueIO has 4 tracked investments across 4 companies. The latest tracked deal is $21.0M Series A in CyberSaint Security in March 2024.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Mar 20, 2024 | CyberSaint Security | $21.0M Series A | JIM Toth | Audeo Capital, Sage Hill Investors |
| Jul 14, 2021 | Virsec | $100.0M Series C | Blueio | John Chambers, Mike Ruettgers, Allen & Company, Arena Holdings, Artiman Ventures, Intuitive Venture Partners, JC2 Ventures, Marker Hill Capital, Quantum Valley Investments |
| Sep 16, 2019 | Wallit | $2.6M Seed | Blueio, BoxOne Ventures, Mendoza Ventures | — |
| Jan 8, 2019 | Greenlight Biosciences | $50.0M Other Equity | Michael Liang, Blueio, Matthew Walker | — |